Literature DB >> 1384047

Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.

S Takahashi1, Y Kawarabayasi, T Nakai, J Sakai, T Yamamoto.   

Abstract

A cDNA that expresses a receptor for very low density lipoprotein (VLDL) was isolated from a rabbit heart cDNA library and characterized. The deduced amino acid sequence of the cDNA revealed that the cDNA encodes a protein with striking homology to the low density lipoprotein (LDL) receptor. Like the LDL receptor, the mature protein consists of the following five domains spanning 846 amino acids: 328 N-terminal amino acids including an 8-fold repeat of 40 amino acids homologous to the ligand binding repeat of the LDL receptor; 396 amino acid residues homologous to the epidermal growth factor precursor including three cysteine-rich repeats; a region immediately outside of the plasma membrane rich in serines and threonines; 22 amino acids traversing the plasma membrane; and 54 amino acids including the NPVY sequence that is required for clustering of the LDL receptor in coated pits and that projects into the cytoplasm. LDL-receptor-deficient Chinese hamster ovary cells transfected with the cDNA bound and internalized VLDL, beta-migrating VLDL, and intermediate density lipoprotein but did not bind LDL with high affinity. The 3.6- and 9.5-kilobase mRNAs for the VLDL receptor are highly abundant in heart, muscle, and adipose tissue. Barely detectable amounts of the mRNAs were present in liver. Based on the structural features, ligand specificity, and tissue expression of the mRNAs, we suggest that this VLDL receptor may mediate uptake of apolipoprotein E-containing lipoproteins enriched with triglyceride in nonhepatic tissues that are active in fatty acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384047      PMCID: PMC50104          DOI: 10.1073/pnas.89.19.9252

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

Authors:  T L Innerarity; R E Pitas; R W Mahley
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

3.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins.

Authors:  T L Innerarity; R W Mahley
Journal:  Biochemistry       Date:  1978-04-18       Impact factor: 3.162

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit.

Authors:  T Yamamoto; R W Bishop; M S Brown; J L Goldstein; D W Russell
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

7.  Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity.

Authors:  D M Kingsley; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Mutational analysis of the ligand binding domain of the low density lipoprotein receptor.

Authors:  V Esser; L E Limbird; M S Brown; J L Goldstein; D W Russell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy.

Authors:  R E Pitas; T L Innerarity; J N Weinstein; R W Mahley
Journal:  Arteriosclerosis       Date:  1981 May-Jun
View more
  106 in total

1.  Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.

Authors:  M Tolar; J N Keller; S Chan; M P Mattson; M A Marques; K A Crutcher
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

Review 2.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

3.  Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated.

Authors:  M Tolar; M A Marques; J A Harmony; K A Crutcher
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

4.  NMR structure of a concatemer of the first and second ligand-binding modules of the human low-density lipoprotein receptor.

Authors:  N D Kurniawan; A R Atkins; S Bieri; C J Brown; I M Brereton; P A Kroon; R Smith
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

5.  Candidate genes for colour and vision exhibit signals of selection across the pied flycatcher (Ficedula hypoleuca) breeding range.

Authors:  P K Lehtonen; T Laaksonen; A V Artemyev; E Belskii; P R Berg; C Both; L Buggiotti; S Bureš; M D Burgess; A V Bushuev; I Krams; J Moreno; M Mägi; A Nord; J Potti; P-A Ravussin; P M Sirkiä; G-P Sætre; W Winkel; C R Primmer
Journal:  Heredity (Edinb)       Date:  2011-10-26       Impact factor: 3.821

6.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

7.  The binding ability analysis of the normal VLDL receptor and its mutant.

Authors:  S Qu; N Feng; Z Liu; H Zhou; Y Deng; Z Feng
Journal:  J Tongji Med Univ       Date:  2001

8.  Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.

Authors:  Guoxiao Wang; Yingying Yu; Weikang Cai; Thiago M Batista; Sujin Suk; Hye Lim Noh; Michael Hirshman; Pasquale Nigro; Mengyao Ella Li; Samir Softic; Laurie Goodyear; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

Review 9.  Causes of dysregulation of lipid metabolism in chronic renal failure.

Authors:  Nosratola D Vaziri
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

10.  Investigation of the distribution and changes of VLDLR subtype in fibrotic cardiac muscles.

Authors:  G Yang; L Bao; J Zhao; S Qu
Journal:  J Tongji Med Univ       Date:  2000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.